"10.1371_journal.pone.0081618","plos one","2013-12-02T00:00:00Z","Peter M Zygmunt; Anna Ermund; Pouya Movahed; David A Andersson; Charlotte Simonsen; Bo A G Jönsson; Anders Blomgren; Bryndis Birnir; Stuart Bevan; Alain Eschalier; Christophe Mallet; Ana Gomis; Edward D Högestätt","Department of Laboratory Medicine, Lund University, Lund, Sweden; Wolfson Centre for Age-Related Diseases, King's College London, London, United Kingdom; Department of Neuroscience, Uppsala University, Uppsala, Sweden; Clermont Université, Université d'Auvergne, Pharmacologie Fondamentale et Clinique de la Douleur, Laboratoire de Pharmacologie, Facultés de Médecine/Pharmacie, Clermont-Ferrand, France; Inserm, U1107 Neuro-Dol, Clermont-Ferrand, France; CHU Clermont-Ferrand, Service de Pharmacologie, Hôpital G. Montpied, Clermont-Ferrand, France; Instituto de Neurociencias, Universidad Miguel Hernández-Consejo Superior de Investigaciones Científicas, Sant Joan d'Alacant, Spain; Lund University Pain Research Centre, Lund University, Lund, Sweden","Conceived and designed the experiments: PMZ EDH. Performed the experiments: A.Ermund PM DAA CS BB SB A.Eshalier CM AG. Analyzed the data: PMZ A.Ermund PM DAA CS BAGJ AB BB SB A.Eshalier CM AG EDH. Wrote the paper: PMZ EDH. Biochemical and vasodilator studies: A.Ermund CS PM. Patch-clamp experiments CHO cells: DA SB. Patch-clamp experiments human TRPV1: BB CS PM. Histamine/TRPV1 patch-clamp experiments: AG. Formalin test: A.Eshalier CM. Mass-spectrometry: AB BAGJ.","The authors have the following interest, AstraZeneca R&D CNS&P Local Discovery Södertälje provided the HEK T-REX hTRPV1 inducible cell line for this study. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.","2013","12","Peter M Zygmunt","PMZ",13,TRUE,2,1,2,2,TRUE,TRUE,TRUE,1,"11",FALSE
